BEYOND AIR INC (XAIR)

Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference

GARDEN CITY, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device...

What's going on in today's pre-market session

The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Get insights into the top gainers and losers of Monday's after-hours session.

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

Revenues increased 17% compared to the previous quarter ended June 30, 2024 Strengthened balance sheet is expected to provide sufficient cash runway...

Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

-  LV UNO in combination with anti-rPD-L1 resulted in prolonged survival and doubled the tumor growth inhibition rate in MAT B III tumor bearing rats...

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

GARDEN CITY, N.Y., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device...

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Submitted abstracts selected for the annual meeting are scheduled to be released to SITC registrants on Tuesday, November 5th at 9:00 AM U.S. ET ...

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

Revolutionary inhaled nitric oxide technology set to reach broader healthcare systems...

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

GARDEN CITY, N.Y., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device...

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

– Retiring $17.5 million in Avenue Capital debt and entering into a $11.5 million loan agreement with an insider-led investor group – – Eliminating $12...

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

– Financing strengthens balance sheet and is expected to provide sufficient cash runway through June 2026 –       – Retiring $17.5 million in Avenue...

Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

GARDEN CITY, N.Y., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device...

Bargain Hunters Take Note: Insider Cluster-Buying At XAIR

XAIR Stock Earnings: Beyond Air Beats EPS, Misses Revenue for Q1 2025

XAIR stock results show that Beyond Air beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025.

XAIR Stock Earnings: Beyond Air Beats EPS, Misses Revenue for Q1 2025

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Beyond Air (NASDAQ:XAIR) just reported results for the first quarter of 2025.Be...

Beyond Air® Reports Fiscal First Quarter 2025 Financial Results and Provides Corporate Update

Revenues increased 45% compared to the previous quarter ended March 31, 2024 Optimized LungFit PH device continues to expand footprint and strengthen...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We have all of the biggest pre-market stock movers that traders are going to want to read about on Tuesday!

Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia

GARDEN CITY, N.Y., July 31, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device...

Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024

GARDEN CITY, N.Y., July 16, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) a commercial stage medical device...

Jefferies Just Raised Its Price Target on Nvidia (NVDA) Stock

Nvidia stock is up on Tuesday after shares of NVDA got an increased price target from Jefferies analysts alongside praise.

Why Is Beyond Air (XAIR) Stock Down 22% Today?

Beyond Air stock is down on Tuesday as investors in XAIR react to the company mixed earnings report for the first quarter of the year.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!

XAIR Stock Earnings: Beyond Air Beats EPS, Misses Revenue for Q4 2024

XAIR stock results show that Beyond Air beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024.

XAIR Stock Earnings: Beyond Air Beats EPS, Misses Revenue for Q4 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Beyond Air (NASDAQ:XAIR) just reported results for the fourth quarter of 2024.B...

Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Appointed industry veteran, David Webster, as new Chief Commercial Officer Recently upgraded LungFit PH device expands customer base; revenue growth...

Beyond Air® Appoints David Webster as Chief Commercial Officer

Mr. Webster brings more than 20 years of executive level experience in the life sciences industry...

Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)

– Ongoing Phase 1a first-in-human clinical trial continues to demonstrate proof of concept for the UNO solid tumor platform with observed early tumor...

Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast

Conference call scheduled for Monday, June 24th at 4:30 pm ET...

Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants

GARDEN CITY, N.Y., March 20, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device...